The U.S. Food and Drug Administration (FDA) has granted fast track designation to the experimental medicine CLN-049, which is being…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted fast track status to zotiraciclib (ZTR/TG02) — an oral medication that…
A new experimental therapy, DT2216, has begun testing in a clinical trial for people with hard-to-treat ovarian cancer, a significant…
Most myeloma patients who started treatment at the Berenson Cancer Center — a clinic in California that specializes…
The Ovarian Cancer Research Alliance (OCRA) launched a project to push lawmakers to enact legislation that will improve the…
Mission Bio has debuted a new laboratory test that enables researchers to simultaneously detect alterations in the genetic code…
Changes in how cells respond to the hormone estrogen may underlie the development of certain forms of pancreatic cancer.
Neonc Technologies has completed enrollment for its Phase 2a clinical trial of NEO100, an intranasal treatment for high-grade glioma,…
A committee of the World Health Organization (WHO) has approved an international nonproprietary name (INN) for Anixa Biosciences’ experimental cell…
Regulators in the U.S. and Europe have approved updates to the prescribing information for Carvykti (ciltacabtagene autoleucel), a…